A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC

BackgroundThe current standard approach to the treatment of patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)—sensitizing mutations has been the treatment with a first-generation EGFR-TKIs. While, with resistance develope...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yongxing Li, Jianye Yang, Yufen Xu, Ming Zhang, Xiaoping Zhang, Wenyu Chen, Xiaodong Lv
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AIMS Press 2019-06-01
Sarja:Mathematical Biosciences and Engineering
Aiheet:
nsclc
first-generation egfr-tkis
second/third-generation egfr-tkis
meta-analysis
Linkit:https://www.aimspress.com/article/10.3934/mbe.2019283?viewType=HTML
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia